Arkolith/Insider Trading/IMMX/Form 4

Chudnovsky Yekaterina

Director, 10% OwnerImmix Biopharma, Inc. (IMMX) · full profile →Form 4 · filed Aug 23, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 22, 2023Grant(A)20K—$020K
Aug 22, 2023Grant(A)17K—$017K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-047062) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML